Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Cardiac Amyloidosis clinical trials
Every US clinical trial registered for Cardiac Amyloidosis — phase mix, recruiting status, and the sponsors running them, straight from the NIH ClinicalTrials.gov registry.
9 US clinical trials · 7 currently recruiting
The research picture
Cardiac Amyloidosis has 9 registered US clinical trials, 7 of them open to new participants right now — about 78% of the total.
- 7
- recruiting participants now
- 78%
- of trials open to enrollment
- 3
- in Phase 3–4 (later-stage)
- 1
- top sponsor: Sharmila Dorbala
Counts reflect the public ClinicalTrials.gov registry as last mirrored by PlainTrial. Status and phase are reported by each study's sponsor. This is reference information, not medical advice.
Active & Recent Trials
Cardiovascular Multimodality Imaging Study
Montefiore Medical Center
NCT06610019
Analysis of Lumbar Spine Stenosis Specimens for Identification of Transthyretin Cardiac Amyloidosis
Columbia University
NCT06034405
Artificial Intelligence Guided Echocardiographic Screening of Rare Diseases (EchoNet-Screening)
Cedars-Sinai Medical Center
NCT05139797
Efficacy of [18F]Florbetaben PET for Diagnosis of Cardiac AL Amyloidosis
Life Molecular Imaging
NCT05184088
US Benchmarking Clinical Study
eMyosound SAS
NCT07215715
Molecular Imaging of Myocardial Fibrosis in Cardiac Amyloidosis
Brigham and Women's Hospital
NCT05619302
CAPACITY (Cardiac Amyloidosis and Physical ACtivITY) Study
Wake Forest University Health Sciences
NCT06096675
Research With I-124 EVuzamitide to Elucidate Cardiac AmyLoidosis
Sharmila Dorbala
NCT06788535
PET/MRI Evaluation of Cardiac Amyloid
Stanford University
NCT03119558
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 3 | 3 |
Top Sponsors
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Reading the Cardiac Amyloidosis Trial Landscape
ClinicalTrials.gov lists 9 US studies indexed under Cardiac Amyloidosis, and 7 of those are currently open to recruitment — roughly 78% of the total volume on the registry. That ratio is a useful proxy for activity level: a high share of recruiting studies often signals that research interest is current and that new enrollment opportunities are appearing, while a low share typically means the field is dominated by completed or follow-up work where most participant spots have already been filled. These counts reflect the public registry only and include studies at every stage of design, so they should be read as an index of research attention rather than as a measure of treatment availability.
The phase distribution for Cardiac Amyloidosis shows 3 late-stage studies (Phase 3 and Phase 4 combined) alongside 1 earlier-phase entries (Phase 1 through Phase 2). Phase 1 and Phase 2 studies focus on early safety signals, dosing, and preliminary effect, while Phase 3 studies are typically the larger efficacy and safety trials submitted toward regulatory review, and Phase 4 studies follow approved interventions in real-world use. A condition weighted toward later phases often reflects a mature research pipeline with several interventions already close to or past approval, whereas a heavier early-phase tilt suggests the field is still exploring new mechanisms and candidate approaches.
Top sponsor activity for Cardiac Amyloidosis is led by Sharmila Dorbala with 1 indexed trial, alongside 8 other organizations in the top contributor list. The list on this page surfaces up to 9 of the most relevant recent and active entries, ordered with recruiting studies first so practical options are visible. All figures are derived from the public ClinicalTrials.gov dataset maintained by the National Library of Medicine and are reproduced here for reference. Inclusion of a trial, sponsor, or intervention on this page is neither an endorsement nor a recommendation — eligibility, protocol changes, and site-level status can shift frequently, so always verify current details on ClinicalTrials.gov and consult a qualified healthcare provider before acting on anything you see here.
Frequently Asked Questions
How many clinical trials are there for Cardiac Amyloidosis?
PlainTrial tracks 9 US clinical trials for Cardiac Amyloidosis, of which 7 are currently recruiting participants. Data sourced from ClinicalTrials.gov.
How do I find a recruiting trial for Cardiac Amyloidosis?
Use the trial list above filtered by "Recruiting" status, or visit our trial finder at /recruiting to search by condition and state. Always discuss trial participation with your healthcare provider before enrolling.
Is this data current?
Data is sourced from ClinicalTrials.gov and reflects our most recent data pull. Trial status may have changed since then. Always verify current information at ClinicalTrials.gov before making decisions about participation.
Related
Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from ClinicalTrials.gov (National Library of Medicine). Consult a qualified professional before making decisions based on this data.
Read our methodology — how this data is sourced, computed, and verified.
Source: ClinicalTrials.gov (NIH/NLM) ClinicalTrials.gov AACT registry · 2026 Trial counts and statuses sourced from ClinicalTrials.gov. Sponsor counts include both industry and federal/academic sponsors.